Food noise or hunger has returned: A sign that a dose is no longer sufficient is the return of intrusive thoughts about food or a noticeable decrease in feelings of fullness after meals
We also see cases where overenthusiastic dosing, opaque compounding, or lack of lifestyle support created avoidable complications
Key factors influencing dose selection include: Treatment goals : Whether the primary aim is glycaemic control, weight reduction, or cardiovascular risk reduction Baseline HbA1c and blood glucose levels : Higher values may eventually require higher maintenance doses Body weight and BMI : Particularly relevant for weight management indications Renal function : Most GLP-1 medications (semaglutide, liraglutide, dulaglutide) do not require dose adjustment for kidney impairment, but exenatide and lixisenatide should be used with caution or avoided in severe renal impairment Concurrent medications : Especially other glucose-lowering agents that might increase hypoglycaemia risk Previous medication tolerance : History of gastrointestinal sensitivity influences titration speed Cardiovascular history : Some GLP-1 medications have proven cardiovascular benefits at specific doses Diabetic retinopathy status : Rapid improvement in blood glucose can temporarily worsen retinopathy, particularly with semaglutide [22] [23] Your doctor will typically schedule regular follow-up appointments during the initial months of treatment
BOTOX results generally last for several months, and continued injections will prolong the desired look
As a result, drugs such as semaglutide and liraglutide became valuable tools not only for glycemic management but also for cardiovascular risk reduction
The maintenance dose pricing has not yet been announced
